Hydrogen bonding patterns and C—H⋯π inter­actions in the structure of the antiparkinsonian drug (R)-rasagiline mesylate determined using laboratory and synchrotron X-ray powder diffraction data

Dugarte-Dugarte, A.J.; Toro, R.A.; van de Streek, J.; Henao, J.A.; Fitch, A.N.; Dejoie, C.; Delgado, J.M.; Díaz de Delgado, G.

doi:10.1107/S2052520623007758

Acta Crystallographica Section B
Acta Crystallographica
Section B STRUCTURAL SCIENCE, CRYSTAL ENGINEERING AND MATERIALS

IUCr IT WDC

home archive editors for authors for readers submit subscribe open access

view article

Figure 4
Superposition of the experimentally determined (red) and the energy-minimized (blue) structure for (R)-RasH⁺·Mes⁻ using: (a) laboratory data and (b) synchrotron radiation data.

STRUCTURAL SCIENCE
CRYSTAL ENGINEERING
MATERIALS

ISSN: 2052-5206

Volume 79| Part 6| December 2023| Pages 462-472

https://doi.org/10.1107/S2052520623007758

Open

access

Follow Acta Cryst. B

Search IUCr Journals		doi		Advanced search
Author		volume	page